ROBERTS 064 (Agrylin 1 mg)
Generic Name: anagrelide
Pill imprint ROBERTS 064 has been identified as Agrylin 1 mg.
Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Agrylin 1 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- anagrelide
- Imprint:
- ROBERTS 064
- Strength:
- 1 mg
- Color:
- Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous uncategorized agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Shire US Inc.
More about Agrylin (anagrelide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
